Hisamitsu Pharmaceutical Co (TSE:4530) Days Sales Outstanding : 107.39 (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Days Sales Outstanding?

Hisamitsu Pharmaceutical Co's average Accounts Receivable for the three months ended in Nov. 2023 was 円42,190 Mil. Hisamitsu Pharmaceutical Co's Revenue for the three months ended in Nov. 2023 was 円35,850 Mil. Hence, Hisamitsu Pharmaceutical Co's Days Sales Outstanding for the three months ended in Nov. 2023 was 107.39.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

TSE:4530' s Days Sales Outstanding Range Over the Past 10 Years
Min: 87.61 Med: 102.33 Max: 141.49
Current: 106.34

During the past 13 years, Hisamitsu Pharmaceutical Co's highest Days Sales Outstanding was 141.49. The lowest was 87.61. And the median was 102.33.

TSE:4530's Days Sales Outstanding is ranked worse than
77.02% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs TSE:4530: 106.34

Hisamitsu Pharmaceutical Co's Days Sales Outstanding increased from Nov. 2022 (106.88) to Nov. 2023 (107.39).

Hisamitsu Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Days Sales Outstanding Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Days Sales Outstanding

Get a 7-Day Free Trial

115.45

141.49

118.51

111.66

107.22

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Days Sales Outstanding	Get a 7-Day Free Trial															97.37	112.03	105.64	107.39	100.51

Competitive Comparison of Hisamitsu Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hisamitsu Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Days Sales Outstanding falls into.

Hisamitsu Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hisamitsu Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Feb. 2024 is calculated as

	Days Sales Outstanding (A: Feb. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Feb. 2023 )	+	Accounts Receivable (A: Feb. 2024 ))	/	count )	/	Revenue (A: Feb. 2024 )	*	Days in Period
=	( (40014	+	43237)	/	2 )	/	141706	*	365
=	41625.5					/	141706	*	365
=	107.22

Hisamitsu Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Nov. 2023 is calculated as:

	Days Sales Outstanding (Q: Nov. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Aug. 2023 )	+	Accounts Receivable (A: Nov. 2023 ))	/	count )	/	Revenue (A: Nov. 2023 )	*	Days in Period
=	( (41967	+	42412)	/	2 )	/	35850	*	365 / 4
=	42189.5					/	35850	*	365 / 4
=	107.39

Hisamitsu Pharmaceutical Co (TSE:4530) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Hisamitsu Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines